{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:27:20Z","timestamp":1777343240776,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.iac.2019.09.011","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T10:19:09Z","timestamp":1572689949000},"page":"41-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sublingual Immunotherapy for Other Indications"],"prefix":"10.1016","volume":"40","author":[{"given":"Derek M.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore M.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2019.09.011_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaci.2008.03.031","article-title":"Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trial","volume":"122","author":"Severino","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.011_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaci.2008.10.028","article-title":"Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy","volume":"123","author":"Rueff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.011_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/039463200802100321","article-title":"Sublingual desensitization in patients with wasp venom allergy: preliminary results","volume":"21","author":"Patriarca","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.iac.2019.09.011_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1034\/j.1398-9995.2001.00904.x","article-title":"Latex rush desensitization","volume":"56","author":"Nucera","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.011_bib5","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1213\/00000539-200210000-00031","article-title":"Sublingual desensitization: a new approach to latex allergy problem","volume":"95","author":"Patriarca","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1016\/j.iac.2019.09.011_bib6","first-page":"17","article-title":"Tolerance and effects on skin reactivity to latex of sublingual rush immunotherapy with a latex extract","volume":"14","author":"Cistero Bahima","year":"2004","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.011_bib7","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1185\/030079906X115711","article-title":"Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study","volume":"22","author":"Bernardini","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.iac.2019.09.011_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000095463","article-title":"Specific immunotherapy with standardized latex extract versus placebo in latex-allergic patients","volume":"141","author":"Tabar","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.011_bib9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2133.2006.07738.x","article-title":"Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study","volume":"156","author":"Nettis","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2019.09.011_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.anai.2010.01.014","article-title":"Latex sublingual immunotherapy: can its safety be predicted?","volume":"104","author":"Buyukozturk","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.011_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1745-6215-12-191","article-title":"Randomized, double-blind, placebo controlled clinical trial of sublingual immunotherapy in natural rubber latex allergic patients","volume":"12","author":"Gastaminza","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.iac.2019.09.011_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.anai.2012.03.005","article-title":"Component resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in children","volume":"108","author":"Lasa Luaces","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2019.09.011_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5114\/ada.2018.75235","article-title":"Latex immunotherapy: evidence of effectiveness","volume":"35","author":"Nucera","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.iac.2019.09.011_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1185\/030079908X291903","article-title":"Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase","volume":"24","author":"Nucera","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.iac.2019.09.011_bib15","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1185\/03007995.2010.490671","article-title":"The safety of a novel sublingual rush induction phase for latex desensitization","volume":"26","author":"Nettis","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.iac.2019.09.011_bib16","first-page":"18","article-title":"Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis","volume":"22","author":"Galli","year":"1994","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.iac.2019.09.011_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaci.2007.04.008","article-title":"Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study","volume":"120","author":"Pajno","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2019.09.011_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1398-9995.2011.02719.x","article-title":"EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference","volume":"67","author":"Schram","year":"2012","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.iac.2019.09.011_bib19","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/ijd.12302","article-title":"Clinical efficacy and compliance of sublingual immunotherapy with Dermatophagoides farinae drops in patients with atopic dermatitis","volume":"53","author":"Qin","year":"2014","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2019.09.011_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.anai.2014.09.009","article-title":"Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, open, parallel-group study","volume":"113","author":"Di Rienzo","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2019.09.011_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5021\/ad.2017.29.1.1","article-title":"Effectiveness of specific sublingual immunotherapy in Korean patients with atopic dermatitis","volume":"29","author":"You","year":"2017","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.iac.2019.09.011_bib22","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1067\/mai.2003.1497","article-title":"Severe anaphylaxis to kiwi fruit: immunologic changes related to successful sublingual allergen immunotherapy","volume":"111","author":"Mempel","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2019.09.011_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jaci.2006.09.041","article-title":"Life-threatening anaphylaxis to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation","volume":"119","author":"Kerzl","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.iac.2019.09.011_bib24","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1398-9995.2006.01196.x","article-title":"Sublingual immunotherapy for cow's milk protein allergy: a preliminary report","volume":"61","author":"de Boissieu","year":"2006","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2019.09.011_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/mnfr.200400037","article-title":"Food allergy to apple and specific immunotherapy with birch pollen","volume":"48","author":"Hansen","year":"2004","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"10.1016\/j.iac.2019.09.011_bib26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000323909","article-title":"Birch-Apple syndrome treated with birch pollen immunotherapy","volume":"156","author":"Mauro","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.iac.2019.09.011_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaci.2012.06.039","article-title":"Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy","volume":"131","author":"Geroldinger-Simic","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2019.09.011_bib28","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jaci.2017.07.036","article-title":"Efficacy and safety of 4\u00a0months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen\u2013related apple allergy","volume":"141","author":"Kinaciyan","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2019.09.011_bib29","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaci.2005.08.027","article-title":"Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract","volume":"116","author":"Enrique","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.011_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1081-1206(10)60456-5","article-title":"Sublingual immunotherapy for hazelnut food allergy: a follow-up study","volume":"100","author":"Enrique","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.011_bib31","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1398-9995.2008.01921.x","article-title":"Randomized double blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract","volume":"64","author":"Fernandez-Rivas","year":"2009","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2019.09.011_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/cea.12901","article-title":"The clinical and immunological effects of Pru p 3 sublingual immunotherapy on peach and peanut allergy in patients with systemic reactions","volume":"47","author":"Gomez","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.011_bib33","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaci.2010.12.1083","article-title":"Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization","volume":"127","author":"Kim","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.011_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2019.07.030","article-title":"Long-term sublingual immunotherapy for peanut allergy in children: clinician and immunologic evidence of desensitization","author":"Kim","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.011_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2012.11.011","article-title":"Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial","volume":"131","author":"Fleischer","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2019.09.011_bib36","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jaci.2014.12.1917","article-title":"Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicenter trial","volume":"135","author":"Burks","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2019.09.011_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2011.10.023","article-title":"The safety and efficacy of sublingual and oral immunotherapy for milk allergy","volume":"129","author":"Keet","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2019.09.011_bib38","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jaci.2014.11.005","article-title":"A\u00a0randomized, double blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy","volume":"135","author":"Narisety","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:42:36Z","timestamp":1760179356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856119300736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0889856119300736"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.011","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sublingual Immunotherapy for Other Indications","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}